Fatty Liver Disease and Multi-System Complications | EK28
Short Talk: HHcy is a Feature and Mediator of NASH that Permits B12 and Folate to be an Effective Therapy for NASH
Mar 24, 2021 1:00pm ‐ Mar 24, 2021 1:15pm
, PhD, Duke-NUS Medical School Singapore
You must be logged in and own this session in order to post comments.
© 2021 Keystone Symposia & Digitell, Inc. All Rights Reserved